quadazocine has been researched along with clocinnamox in 1 studies
Studies (quadazocine) | Trials (quadazocine) | Recent Studies (post-2010) (quadazocine) | Studies (clocinnamox) | Trials (clocinnamox) | Recent Studies (post-2010) (clocinnamox) |
---|---|---|---|---|---|
81 | 0 | 0 | 48 | 0 | 6 |
Protein | Taxonomy | quadazocine (IC50) | clocinnamox (IC50) |
---|---|---|---|
Mu-type opioid receptor | Homo sapiens (human) | 0.0005 | |
Delta-type opioid receptor | Homo sapiens (human) | 0.0002 | |
Kappa-type opioid receptor | Homo sapiens (human) | 0.0001 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
DeYoung, MB; Lewis, JW; Sumpter, TL; Traynor, JR; Vivian, JA; Woods, JH | 1 |
1 other study(ies) available for quadazocine and clocinnamox
Article | Year |
---|---|
kappa-Opioid receptor effects of butorphanol in rhesus monkeys.
Topics: Analgesics, Opioid; Animals; Azocines; Benzeneacetamides; Butorphanol; Cinnamates; Conditioning, Operant; Discrimination Learning; Diuresis; Dose-Response Relationship, Drug; Ethylketocyclazocine; Female; Injections, Intramuscular; Macaca mulatta; Male; Morphine Derivatives; Nalbuphine; Narcotic Antagonists; Pyrrolidines; Receptors, Opioid, kappa | 1999 |